diabetes mellitus, type 2

Showing NaN - NaN of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart, insulin glargine, metformin)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • biphasic insulin aspart
  • +3 more
  • Ebreichsdorf, Austria
  • +53 more
Jan 5, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart, biphasic human insulin)

Completed
  • Diabetes
  • +2 more
  • biphasic insulin aspart
  • biphasic human insulin
  • Graz, Austria
  • +36 more
Jan 3, 2017

Diabetes, Type 2 Trial in Worldwide (Canagliflozin, 100 mg, Canagliflozin, 300 mg, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Canagliflozin, 100 mg
  • +2 more
  • Montgomery, Alabama
  • +56 more
Oct 28, 2016

Diabetes, Type 2 Trial in Czech Republic, Germany, Romania (TANTALUS System)

Terminated
  • Diabetes Mellitus, Type 2
  • TANTALUS System
  • Brno, Czech Republic
  • +12 more
Sep 21, 2016

Diabetes, Type 2 Trial in Worldwide (Rosiglitazone/metformin)

Completed
  • Diabetes Mellitus, Type 2
  • Vienna, Austria
  • +92 more
Aug 31, 2016

Diabetes, Type 2 Trial in Worldwide (BI 10773, BI 10773 Placebo, BI 10773 / BI 1356)

Completed
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +3 more
  • Chino, California
  • +113 more
Mar 4, 2016

Diabetes, Type 2 Trial in Worldwide (Insulin Glargine (Lantus®), Inhaled Human Insulin (Exubera®))

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Glargine (Lantus®)
  • Inhaled Human Insulin (Exubera®)
  • Bornem, Belgium
  • +61 more
Jun 30, 2015

Diabetes, Type 2 Trial in Worldwide (LY2189265, Sitagliptin, Placebo solution)

Completed
  • Diabetes Mellitus, Type 2
  • Peoria, Arizona
  • +98 more
Mar 31, 2015

Diabetes, Type 2 Trial in Worldwide (Exenatide (AC2993), Insulin glargine)

Completed
  • Diabetes Mellitus, Type 2
  • Exenatide (AC2993)
  • Insulin glargine
  • San Diego, California
  • +90 more
Mar 19, 2015

Diabetes, Type 2 Trial in Worldwide (exenatide, biphasic insulin aspart)

Completed
  • Diabetes Mellitus, Type 2
  • Osijek, Croatia
  • +68 more
Mar 19, 2015

Diabetes, Type 2 Trial in Worldwide (LY2963016, Lantus, OAMs)

Completed
  • Diabetes Mellitus, Type 2
  • Montgomery, Alabama
  • +61 more
Dec 2, 2014

Diabetes, Type 2 Trial in Worldwide (metformin , linagliptin , metformin)

Completed
  • Diabetes Mellitus, Type 2
  • metformin placebo
  • +3 more
  • Dhaka, Bangladesh
  • +89 more
Nov 13, 2014

Diabetes, Type 2 Trial in Worldwide (Pioglitazone 15 mg, Pioglitazone 45 mg, Pioglitazone 30 mg)

Completed
  • Diabetes Mellitus, Type 2
  • Pioglitazone 15 mg
  • +6 more
  • Birmingham, Alabama
  • +131 more
Oct 9, 2014

Diabetes, Type 2, Diabetes, Endocrine System Diseases Trial in Worldwide (JNJ16269110, Placebo, Metformin)

Completed
  • Diabetes Mellitus, Type 2
  • +3 more
  • Edegem, Belgium
  • +62 more
Jul 10, 2014

Diabetes, Type 2 Trial in Worldwide (BI 10773, , metformin)

Completed
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +2 more
  • Capital Federal, Argentina
  • +73 more
May 16, 2014

Diabetes, Type 2 Trial in Worldwide (BI 10773, Metformin, Sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +2 more
  • Mission Viejo, California
  • +136 more
May 16, 2014

Diabetes, Type 2 Trial in Worldwide (BI 10773, , sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • BI 10773
  • +2 more
  • Chula Vista, California
  • +115 more
May 16, 2014

Diabetes, Type 2 Trial in Worldwide (Placebo identical to BI 1356 5mg, Placebo identical to Glimepiride 1mg or 2mg or 3mg or 4

Completed
  • Diabetes Mellitus, Type 2
  • Placebo identical to BI 1356 5mg
  • +3 more
  • Tempe, Arizona
  • +220 more
Dec 11, 2013

Diabetes, Type 2 Trial in Worldwide (Canakinumab, Metformin, Placebo)

Terminated
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Jan 17, 2012

Diabetes, Type 2 Trial in Worldwide (LY2428757, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Bermuda Dunes, California
  • +59 more
Jul 12, 2011

Diabetes, Type 2 Trial in Worldwide (Insulin Glargine, Insulin Lispro Protamine Suspension (ILPS), Insulin Lispro)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin Glargine
  • +2 more
  • Genk, Belgium
  • +49 more
May 11, 2011

Diabetes, Type 2 Trial in Worldwide (GALIDA)

Terminated
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +129 more
Nov 18, 2010

Diabetes, Type 2 Trial in Worldwide (Placebo, PF-00734200 10 mg QD, PF-00734200 20 mg QD)

Completed
  • Diabetes Mellitus, Type 2
  • Placebo
  • +4 more
  • Birmingham, Alabama
  • +78 more
Jun 22, 2010